T. Rowe Price Associates’s Marex Group Limited Ordinary Shares MRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$300M Buy
4,923,341
+3,017,312
+158% +$166M 0.03% 390
2026
Q1
$85M Buy
1,906,029
+357,392
+23% +$14.1M 0.01% 643
2025
Q4
$59.4M Buy
1,548,637
+337,444
+28% +$11.5M 0.01% 761
2025
Q3
$40.7M Buy
1,211,193
+1,195,294
+7,518% +$43.2M ﹤0.01% 866
2025
Q2
$628K Buy
+15,899
New +$662K ﹤0.01% 2202

Other funds holding MRX

T. Rowe Price Associates's MRX Position: Q2 2026 in Review

T. Rowe Price Associates increased its Marex Group Limited Ordinary Shares (MRX) stake by 158% in Q2 2026, buying an estimated $166M and bringing the position to 4,923,341 shares worth $300M. The position accounts for 0.03% of the portfolio, ranked #390.

T. Rowe Price Associates first reported a position in MRX in Q2 2025 and has held it in 5 quarters since. 221 funds tracked by Wall St. Rank hold MRX as of Q2 2026.

  • T. Rowe Price Associates held 4,923,341 shares of Marex Group Limited Ordinary Shares worth $300M as of Q2 2026.
  • T. Rowe Price Associates bought 3,017,312 Marex Group Limited Ordinary Shares shares in Q2 2026, an estimated $166M.
  • Marex Group Limited Ordinary Shares made up 0.03% of T. Rowe Price Associates's portfolio in Q2 2026, its #390 holding.
  • T. Rowe Price Associates first reported a position in Marex Group Limited Ordinary Shares in Q2 2025 and has held it in 5 quarters since.
  • 221 funds tracked by Wall St. Rank held Marex Group Limited Ordinary Shares as of Q2 2026.

Based on T. Rowe Price Associates's 13F filing for Q2 2026, filed 14 Aug 2026.